FUBP3 and chronic myelogenous leukemia, BCR-ABL1 positive: The decrease in FUBP3 expression was significantly associated with a higher percentage of myeloblasts (r = −0.345, p = 0.016), high TC (r = −0.439, p = 0.002) and low Hb levels in CML patients (r = 0.294, p = 0.043) (Figure 2B–D; Table S4).